42 results on '"Johnson, Margaret O."'
Search Results
2. NUTMEG: A randomized phase II study of nivolumab and temozolomide versus temozolomide alone in newly diagnosed older patients with glioblastoma
3. Easing the Journey—an Updated Review of Palliative Care for the Patient with High-Grade Glioma
4. Palliative Care Use for Critically Ill Patients With Brain Metastases
5. QLTI-06. EVALUATING TWO DECADES OF GLIOBLASTOMA CARE IN THE UNITED STATES VETERANS HEALTH ADMINISTRATION
6. INNV-15. OPTIMIZING THE ROLE OF THE ADVANCED PRACTICE PROVIDER IN THE MANAGEMENT OF A SINGLE PATIENT INVESTIGATIONAL NEW DRUG (IND)
7. CTIM-10. A SURGICAL WINDOW-OF-OPPORTUNITY CLINICAL TRIAL EVALUATING THE PCSK9 INHIBITOR EVOLOCUMAB IN PATIENTS WITH GLIOMA
8. DDDR-29. TARGETING FGFR FUSIONS: A CASE OF CATEQUENTINIB (AL3818) AND TEMOZOLOMIDE COMBINATION THERAPY FOR RECURRENT MGMT METHYLATED TACC-FGFR FUSION POSITIVE GLIOBLASTOMA
9. EPID-30. DYSPHAGIA-RELATED HEALTHCARE UTILIZATION AMONG OLDER PATIENTS WITH PRIMARY AND METASTATIC BRAIN TUMORS: A NATIONAL STUDY OF MEDICARE BENEFICIARIES
10. CTIM-09. PHASE 1/1B TRIAL OF FC-ENGINEERED ANTI-CD40 AGONIST MONOCLONAL ANTIBODY (2141-V11) INFUSED WITH D2C7-IT IN ENHANCING DISEASE BY CONVECTION-ENHANCED DELIVERY (CED) FOR RECURRENT MALIGNANT GLIOMA (RMG)
11. EOLP-05. SUPPLEMENTAL ENTERAL NUTRITION DOES NOT IMPROVE SURVIVAL IN OLDER PATIENTS WITH PRIMARY MALIGNANT BRAIN TUMORS
12. QLTI-05. COST TOXICITY OF ORAL CHEMOTHERAPY IN PRIMARY BRAIN TUMOR PATIENTS
13. RTID-07. A RANDOMIZED WINDOW OF OPPORTUNITY TRIAL WITH DOSE ESCALATION TO EVALUATE FLUOXETINE AND TEMOZOLOMIDE IN GLIOMA
14. MGMT ProFWise: Unlocking a New Application for Combined Feature Selection and the Rank-Based Weighting Method to Link MGMT Methylation Status to Serum Protein Expression in Patients with Glioblastoma.
15. Use, access, and initial outcomes of off-label ivosidenib in patients with IDH1 mutant glioma.
16. Evolving Barriers to Clinical Trial Enrollment and Clinical Care in Neuro-oncology in the Face of COVID-19.
17. Use, Access, and Initial Outcomes of Off-Label Ivosidenib in Patients with IDH1 Mutant Glioma
18. Characterization of industry relationships in oncology
19. S396 Higher Rates of Dysphagia Incidence Among Patients With Malignant Primary Brain Tumors Compared to Brain Metastases: A National Study of Medicare Beneficiaries
20. Racial disparities in inpatient clinical presentation, treatment, and outcomes in brain metastasis
21. Characterization of industry relationships in oncology.
22. A phase 1 trial of D2C7-it in combination with an Fc-engineered anti-CD40 monoclonal antibody (2141-V11) administered intratumorally via convection-enhanced delivery for adult patients with recurrent malignant glioma (MG).
23. A phase 0/surgical window-of-opportunity study in progress, evaluating evolocumab in patients with high-grade glioma or glioblastoma.
24. Racial disparities in inpatient clinical presentation, treatment, and outcomes in brain metastasis.
25. Validation of an Online Calculator to Predict Short-term Postoperative Outcomes in Patients with Metastatic Brain Tumors
26. Primary brain tumor patients admitted to a US intensive care unit: a descriptive analysis
27. Treatment Complications of Venous Thromboembolism in Patients with Central Nervous System Tumors
28. The mutational landscape of older patients with IDH wild-type glioblastoma (GBM).
29. Adjuvant radiation in older patients with glioblastoma: a retrospective single institution analysis
30. Adjuvant Radiation in Older Patients With Glioblastoma: A Retrospective Single Institution Analysis
31. Glioblastoma as an age-related neurological disorder in adults
32. Phase I trial of D2C7 immunotoxin (D2C7-IT) administered intratumorally via convection-enhanced delivery (CED) for recurrent malignant glioma (MG).
33. Patterns of relapse after successful completion of initial therapy in primary central nervous system lymphoma: a case series
34. The role of chemotherapy in the treatment of central neurocytoma
35. Utilization of Hospice Services in a Population of Patients With Huntington's Disease
36. Oncolytic polio/rhinovirus recombinant (PVSRIPO) against WHO grade IV malignant glioma (MG): Experience with retreatment of survivors from the phase I trial.
37. Performance of a nomogram for IDH-wild-type glioblastoma patient survival in an elderly cohort
38. An adult with recurrent atypical teratoid rhabdoid tumor of the spine
39. RARE-25. A RETROSPECTIVE, SINGLE INSTITUTION STUDY OF CENTRAL NEUROCYTOMA (2004-2016): SURVIVAL, TREATMENT, AND SUPPORTIVE CARE
40. ACTR-64. PHASE 2 STUDY OF SYM004 FOR ADULT PATIENTS WITH RECURRENT GLIOBLASTOMA (GBM)
41. 19-Year-Old Male with Headaches and a Possible Seizure
42. Bibliography.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.